Gossamer Bio (GOSS) News and press releases

HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $5 Price Target

11 May 23

News, Price Target, Reiteration, Analyst Ratings

HC Wainwright & Co. analyst Patrick Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a Buy and maintains $5 price target.

Stocks That Hit 52-Week Lows On Tuesday

18 Apr 23

Options

On Tuesday, 91 stocks hit new 52-week lows.

Skillz And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

6 Apr 23

Long Ideas, News, Penny Stocks, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas

The Dow Jones closed higher by around 80 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

After Pausing Recruitment, Gossamer Bio Terminates All Studies With CNS Lymphoma Candidate

4 Apr 23

Biotech, News, Penny Stocks, Health Care, FDA, General

Barclays Maintains Equal-Weight on Gossamer Bio, Lowers Price Target to $1.5

21 Mar 23

News, Price Target, Analyst Ratings

Barclays analyst Carter Gould maintains Gossamer Bio (NASDAQ:GOSS) with a Equal-Weight and lowers the price target from $2 to $1.5.

Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session

20 Mar 23

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers

12 Health Care Stocks Moving In Monday's Intraday Session

20 Mar 23

Movers

Gossamer Bio Q4 EPS $(0.59) Beats $(0.62) Estimate

17 Mar 23

Earnings, News

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.59) per share which beat the analyst consensus estimate of $(0.62) by 4.84 percent. This is a 20.27 percent increase over losses of $(0.74) per share from the

Stocks That Hit 52-Week Lows On Thursday

16 Mar 23

Options

Thursday's session saw 337 companies set new 52-week lows.

Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

16 Mar 23

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for hemorrhagic cystitis.

12 Health Care Stocks Moving In Thursday's Intraday Session

16 Mar 23

Movers

12 Health Care Stocks Moving In Monday's After-Market Session

13 Mar 23

Movers

Stocks That Hit 52-Week Lows On Friday

10 Mar 23

Options

On Friday, 497 companies set new 52-week lows.

Gossamer Bio Announces TORREY Data to be Featured at American Thoracic Society 2023 International Conference

18 May 23

Press Releases

Gossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH), today announced

Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update

9 May 23

Press Releases

- Feedback on Planned Registrational Program for Seralutinib Received from FDA and EMA following Successful Phase 2 TORREY Study - - Registrational Phase 3 Clinical Trial in PAH Patients Expected to Initiate in 3Q23

Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update

17 Mar 23

Press Releases

- FDA Feedback on Seralutinib Phase 3 Clinical Trial Received; Expected to Commence in the Second Half of 2023 - - Topline Data from TORREY Study Open-Label Extension Expected in Mid-2023 - - Enrollment in GB5121